Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.

about

Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.

Item

http://www.wikidata.org/entity/Q36335451

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pretreatment with oral contrac ...... ot perspective study proposal.

@ast

Pretreatment with oral contrac ...... ot perspective study proposal.

@en

type

Item

label

Pretreatment with oral contrac ...... ot perspective study proposal.

@ast

Pretreatment with oral contrac ...... ot perspective study proposal.

@en

prefLabel

Pretreatment with oral contrac ...... ot perspective study proposal.

@ast

Pretreatment with oral contrac ...... ot perspective study proposal.

@en

P1476

Pretreatment with oral contrac ...... ot perspective study proposal.

@en

P2093

Alessandra Andrisani

http://www.w3.org/2001/XMLSchema#string

Giovanni Battista Nardelli

http://www.w3.org/2001/XMLSchema#string

Guido Ambrosini

http://www.w3.org/2001/XMLSchema#string

Marco Noventa

http://www.w3.org/2001/XMLSchema#string

Michele Gangemi

http://www.w3.org/2001/XMLSchema#string

Salvatore Gizzo

http://www.w3.org/2001/XMLSchema#string

P2860

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?

Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART.

Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing.

Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.

The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.

Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.

Mutations and polymorphisms in FSH receptor: functional implications in human reproduction.

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.

P304

1692-1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2015.2734

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282896002

http://www.w3.org/2001/XMLSchema#string

P698

26640538

http://www.w3.org/2001/XMLSchema#string

P932

4665651

http://www.w3.org/2001/XMLSchema#string